Shanghai No.1 Pharmacy (600833.SH): Plans to sign a housing expropriation compensation agreement.

On February 11, GeLong Hui reported that Shanghai No.1 Pharmacy (600833.SH) announced that, according to the "Decision on Housing Expropriation by the People's Government of Huangpu District, Shanghai" (Huangfu Zheng [2023] No. 4), the company's properties located at 553-555 Sichuan Middle Road, 545 Sichuan Middle Road, and 639 Sichuan Middle Road in Huangpu District, Shanghai have been included in the expropriation scope. The above three properties are managed and operated by our company and were mainly used for external rental purposes. The unit responsible for the housing expropriation is the "Huangpu District Housing Security and Housing Management Bureau of Shanghai", and the implementation unit is the "Fifth Housing Expropriation Office of Huangpu District, Shanghai".

Gelonghui FinanceFeb 11 17:36

First Pharmaceutical: Shanghai First Pharmaceutical Co., Ltd. 2024 Annual Results Forecast

SZSIJan 23 00:00 · Announcements

Shanghai First Pharmaceutical Co., Ltd. 2024 Annual Results Forecast

SZSIJan 23 00:00 · Announcements

Shanghai No.1 Pharmacy (600833.SH): Expected net income in 2024 will increase by 38.9% to 107.22% year-on-year.

On January 22, 2024, Zhongxin reported that Shanghai No.1 Pharmacy (600833.SH) announced that 1. According to preliminary calculations by the company's finance department, it is expected to achieve a net income attributable to the parent company owners of 124 million yuan to 185 million yuan in 2024, which represents an increase of 34.7248 million yuan to 95.7248 million yuan compared to the same period last year, a year-on-year increase of 38.90% to 107.22%. 2. It is expected that the company will achieve a net income attributable to parent company owners, excluding non-recurring gains and losses, of 6 million yuan to 9 million yuan in 2024, which represents a decrease of 1.8758 million yuan compared to the same period last year.

Gelonghui FinanceJan 22 17:30

Shanghai No.1 Pharmacy (600833): Parent company's net income has increased significantly, and diversified development is setting sail.

Event: The company recently released the performance forecast for the year 2024: it is expected to achieve a Net income of 1.24 to 0.185 billion, an increase of 38.90% to 107.22% year-on-year; it is expected to achieve a Net income for 2024.

东北证券Jan 22 00:00

The A-shares in the State-owned Assets Reform in Shanghai Sector surged, with multiple stocks including Shanghai No.1 Pharmacy hitting the daily limit.

On December 12, according to Gelonghui, Shanghai No.1 Pharmacy, Shanghai Yimin Commercial Group, Shanghai Kai Kai Industrial, and Shanghai Phoenix Enterprise reached the daily price limit, while Shanghai Join Buy rose over 8%.

Gelonghui FinanceDec 12, 2024 10:14